HYBRID EVENT: You can participate in person at Valencia, Spain or Virtually from your home or work.
Cardiovascular Pharmacology

Cardiovascular Pharmacology involves the study of how drugs interact with the cardiovascular system to produce their effects. These effects are typically characterized by changes in the function of the heart, blood vessels, and other components of the circulatory system. Pharmacodynamic considerations include the mechanisms by which drugs exert their influence, such as receptor interactions, signal transduction pathways, and alterations in cellular function.

For instance, beta-blockers act by blocking beta-adrenergic receptors, leading to reduced heart rate and contractility. Calcium channel blockers inhibit the entry of calcium ions into cardiac and smooth muscle cells, resulting in vasodilation and decreased cardiac contractility. Antiplatelet agents, like aspirin, interfere with platelet function to prevent blood clot formation.

Understanding pharmacodynamics is crucial in tailoring drug therapy for cardiovascular conditions, as it allows for precise targeting of specific pathways to achieve therapeutic effects while minimizing adverse reactions. It plays a vital role in optimizing treatment strategies for conditions such as hypertension, heart failure, and arrhythmias.

Committee Members
Speaker at Pharmaceutical Conference - Consolato M Sergi

Consolato M Sergi

Universities of Alberta and Ottawa, Canada
Speaker at Drug Delivery Events - Vladlen Slepak

Vladlen Slepak

University of Miami Miller School of Medicine, United States
Speaker at Drug Delivery Events -  Andreas M Papas

Andreas M Papas

Antares Health Products, United States
Speaker at Drug Delivery Events - Sergey Suchkov

Sergey Suchkov

The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation

Submit your abstract Today

Watsapp